Subsequently, in a HNSCC cell model system [14], the signaling by FGFR3-TACC3 fusion protein was further characterized as a novel mechanism of resistance to EGFR/ERBB3 inhibition. This evidence concerns the gene FGFR3 and head and neck squamous cell carcinoma.